Activation of integrin and organization of cytoskeletal proteins are highly regulated in cell adhesion and aggregation. The interaction of leukocyte function-associated antigen-1 (LFA-1) and intercellular adhesion molecules-I (CAM-1) mediates cell adhesion and aggregation, which facilitate leukocyte trafficking to inflamed tissues and augment effector functions. We investigated how LFA-l/ICAM-l -mediated adhesion and aggregation are regulated in HL-60 cells induced to differentiate into neutrophils by retinoic acid (RAJ.
CAM-1 was intensely expressed on RA-induced HL-60 cells, these cells did not show any cellular aggregation. The HL-60 cells transfected with the active form of Ras (Val121 exhibited LFA-l/ICAM-l -dependent aggregation by RA stimulation without change in the avidity of LFA-1. In these Ras-transfectants, a cytoskeletal protein, paxillin, was tyrosine-phosphorylated, and the level of F-actin increased. Transforming growth factor (TGFIP, as well as cytochalasin D, prevented both the tyrosine phosphorylation of paxillin and the aggregation without any effects on the avidity of LFA-I. Thus, an increase in the avidity of LFA-1 was not sufficient for the induction of aggregation, which required activation of Ras and reorganization of cytoskeletal proteins. These results suggest that distinct regulatory mechanisms control LFA-I/ICAM-1 -dependent adhesion and aggregation in HL-60 cells differentiating into neutrophils. gers that lead to the active form of LFA-1. It is suggested that the LFA-1 molecule can become activated dependently on the cytoskeletal changes caused by the transmission of intracellular signals.
However, because stimulators such as TPA cause both LFA-l/ICAM-1 -dependent adhesion and aggregation, the molecular mechanisms for each of these processes appear to be difficult to ~l a r i f y .~' -~~ The transmembrane integrin receptors control the localization of specific cytoskeletal proteins such as talin, a-actinin, tensin, vinculin, and p a~i l l i n . ~~ These proteins have been detected in the focal complex that was formed at sites where cells adhere to the extracellular matrix. The integrin also mediates signalling involving tyrosine phosphorylation." Paxillin has been reported to be tyrosine phosphorylated by integrin-mediated signals and is important in cytoskeletal re~rganization.~'-*~ The tyrosine kinase(s) that phosphorylate paxillin are unknown, but in vitro paxillin can be phosphorylated by the focal adhesion tyrosine kinase ~125'*.'~ Recently, Fgr, one of the src family tyrosine kinases, was suggested to phosphorylate paxillin in a 02 integrin-dependent manner in human neutrophils. 29 It was demonstrated that Ras functions downstream of integrin receptor^.^' Ras has been indicated to play important roles in the actin cytoskeletal reorganization. The microinjection of oncogenic Ras into cells induces actin polymerization and assembly of multimolecular focal complexes at the plasma membrane and leads to formation of lamellipodia and membrane r~ffling.~' These actin-based structures were found to be induced synergestically by Rac and Rho, which are members of the Ras superfamily of small guanosine triphosphate (GTP)-binding They are implicated to act downstream of Ras."-" Rho was shown to induce tyrosine phosphorylation of paxillin in an actin cytoskeleton-dependent manner.36
The human promyelocytic leukemia cell line, HL-60, can be differentiated in vitro by stimulation with TPA or retinoic acid (RA) into macrophages or neutrophils, re~pectively.'~ We have molecularly characterized these processes and indicated the involvement of tyrosine kinases and R~s .~* -~' The HL-60 cells have been also used as a model to delineate We show here that RA induces LFA-lfICAh4-1 -dependent adhesion in HL-60 cells, which requires de novo protein synthesis, but does not require an intact actin cytoskeleton. The high avidity state of LFA-1 is not sufficient for the induction of aggregation in RA-stimulated HL-60 cells. The activated Ras induces LFA-1fICAM-1 -dependent aggregation. The LFA-1fICAM-1 -dependent adhesion and aggregation are also differentiated in their sensitivity to the inhibitory effects of cytochalasin D and TGFP. 
MATERIALS AND METHODS

Cells
C
Purification and coating of ICAM-I. ICAM-1 was immunoaffinity purified using anti-ICAM-1 antibody (RR111) Sepharose from mouse IgG-Sepharose-precleared cell lysates prepared from JY cells (1 X 10' ) with lysis buffer (1% Triton X-100, 10 mmol/L. Tris pH8.0, 150 mmol/L NaCl, 2 pg/mL aprotinin, 1 mmol/L phenymethylsulfonyl fluoride (PMSF), 5 mmol/L iodoacetamide).'* The column was washed with 10 mmol/L Tris HCl, pH8.0 containing 150 mmovL NaCl, and 0.1% Triton X-100, followed by 50 m o l / L triethylamine, pH1O.O containing 0.15 mom NaCl and 1% octyl glucopyranoside. ICAM-1 was eluted with 50 mmoYL triethylamine, pH12.5, 0.15 mom NaC1, 1% octyl glucopyranoside, neutralized immediately with 2 mol/L Tris HCl, pH6.0, and stored at -80°C. Purity was more than 95%. and the concentration of proteins was at 10 to 40 pg/mL.
Purified ICAM-1 was adsorbed to polystyrene microtitier plate (Limbro-Flow, McClean, VA) wells by addition of 2 pL of detergent solubilized protein to 100 pL of 20 mmol/L Tris HCl, pH 8.0.0.15 mom NaCl. After a 90-minute incubation at room temperature, the plates were incubated for 30 minutes at room temperature in 1% bovine serum albumin (BSA) in phosphate b u f f e d saline (PBS) and were then washed with assay media. The amount of ICAM-1 for coating was chosen to give a saturated cell binding. In this coating condition, site density was about 1,200 sites/pm2 quantified using '2-'I-labeled RRl/l (2 pci/pg) at a find concentration of 20 pg/mL, the number of which was comparable with that of the previous report.I2 Adhesion assays with coated ICAM-I were performed as described."" Cells were labeled with 2',7'-bis-(2-carboxyethyl)-5 (and -6) carboxyfluorescein (BCECF; Melecular Probes, Inc, Eugene, OR) and suspended with RPMI1640, I O mmoll L Hepes, pH7.4, 5 % FCS. For inhibition, coated wells or labeled cells were incubated with 20 p g h L of the appropriate antibodies for 30 minutes at room temperature before assays. Cells were transfered into coated wells at 5 X 104/well, and then incubated at 37°C for 30 minutes. Nonadherent cells were removed with four 21-gauge needle aspirations. Bound cells were quantitated in the 96-well plate using a fluorescence concentration analyzer (IDEXX Corp. Westbrook, ME). Coating and adhesion assays with fibronectin were performed exactly as described."
The following antibodies were used for immunoprecipitation and immunoblotting: "'I-labeled monoclonal antiphospho- For personal use only. on October 27, 2017. by guest www.bloodjournal.org From
microplates. Two days after transfection. G418 (GIBCO) was added at I mg/mL of the final concentration, and subclones were isolated after 4 to 6 weeks of (3418 treatment and were propagated in the presence of G4 18.
The cellular content of F-actin was analyzed by staining with tetramethylrhodamine isothiocyanate (TRITC) phalloidin, as described." The HL-60 cells or Ras-transfectants were fixed with 4010 (wt/vol) paraformaldehyde on ice and then stained in the dark at room temperature (RT) for 30 minutes by incubation in a mixture of lysophosphatidylcholine (200 pglmL) and TRITC phalloidin (0.6 pglmL). After washing and resuspension in PBS, the fluorescence of samples was analyzed with a spectrofluorometer.
Immunoprecipitation cmd irnmimohlotting. Cell lysates from original or Ras-transfected HL-60 cells were prepared as described.'"
The IO-pL samples of the cell lysates or the immunoprecipitated proteins were subjected to electrophoresis on 9% or 12% polyacrylamidelsodium dodecyl sulfate gel. The transfer of the proteins to a polyvinylidene difluoride (PVDF) membrane and blotting with labeled PY-20 were performed as described?' Monoclonal antibodies plus peroxidase-linked antimouse IgG F (ab)? fragments and an enhanced chemiluminescence (ECL) system (Amersham) were also used for immunoblotting analysis.
Parental and Ras-transfected HL-60 cells were lysed and the lysates were immunoprecipitated with the affinity-purified rabbit polyclonal anti-ERK I (extracellular signal-regulated kinases) or anti-ERK 2 antibodies (Santa Cruz Biotechnology, Inc. Santa Cruz. CA). MAP kinases were determined in immunoprecipitates in a reaction buffer containing I pCi(y-"P)ATP, 20 pmol ATP, and 1.5 mglmL myelin basic protein (MBP Sigma) for 20 minutes at 30°C. as described previously.Jx Deternrination of the cellular content of F-actin.
Mito~en-activate~lprotein kinase (MAP kinase) activities. TPA is a potent activator for adhesion through VLA-4 and LFA-I. When stimulated with TPA for 30 minutes HL-60 cells adhered to fibronectin (FN) in a VLA-4-dependent manner, but could not adhere to ICAM-I , which is a ligand for LFA-I (Fig I B and C) , despite the fact that the expression levels of VLA-4 and LFA-I were comparable. Thus, these results indicate that LFA-I on HL-60 is in the low avidity state even with stimulation and suggest that an avidity of LFA-I could be regulated differentially from that of VLA-4.
RESULTS
Diflerential regulation
RA-induced LFA-I/ICAM-I adhesion. When HL-60 cells were cultured in the presence of 1 j"l/L RA for 24 hours, they became adhered to ICAM-I constitutively without TPA (Fig 2A) . The adhesion was completely dependent on LFA-I/ICAM-I in RA-treated HL-60 cells because antibodies to both LFA-I and ICAM-I blocked adhesion, whereas the antibody to CR3 did not (Fig 2B) . These data showed that RA induced LFA-IIICAM-1 -dependent adhesion of HL-60 cells without any stimuli.
RA stimulation did not augment the expression of LFA-1 (Fig 2C) . This result indicated that an increase in the avidity of LFA-I, rather than the expression on the cell surface, accounted for adhesion to ICAM- cvtoskeleton. Adhesion of HL-60 cells to ICAM-I was examined following the incubation with RA in the presence of 0.1 pg/mL of actinomycin D or 2 pg/mL of cycloheximide for 24 hours. The adhesion was completely blocked by actinomycin D or cycloheximide (Fig 3) . The concentration of these drugs used in our experiments did not exert toxic effects on cell adhesion because the induction of VLA-4-mediated adhesion to FN by TPA was not inhibited in HL-60 cells pretreated with the same doses (data not shown). Thus, de novo synthesis of proteins was required for the induction of LFA-I/ICAM-1 -dependent adhesion by RA.
HL-60 cells were also incubated with RA in the presence of 1 pmol/L of cytochalasin D or 10 ng/mL of TGFO for 24 hours. These agents were maintained in the assay during the subsequent 30-minute cell adhesion assay. The induction of LFA-I/ICAM-I -dependent adhesion by RA was not inhibited by cytochalasin D or TGFp (Fig 3) .
Rns induces LFA-I/ICAM-I -dependent aggregation in RA-treated HL-60 cells. Activated Val-I2 Ras (Ras with valine at residue 12) was ligated to the inducible metallothionein promotor and was introduced into HL-60 cells. We selected the clones (no. 20 and 28). the basal expressions of which were twofold to threefold more than those in the parental HL-60 cells and increased fivefold more 24 hours after stimulation with Cd' (Fig 4A) . We confirmed that the activity of Map kinases increased in these Ras-transfectants (Fig 4B) . The clone, which expressed only the neomycinresistant gene and did not show the increased levels of Ras protein even if exposed to Cd', was selected and used as a negative control (Fig 4A) . Although parental HL-60 cells and the negative control clone did not aggregate due to RA stimulation, Ras-transfected clones (no. 28 and 20) aggregated drastically 48 hours after RA stimulation (Fig 4C) . Cellular aggregation of Ras-transfectants by RA was inhibited by the anti-LFA-1 or anti-ICAM-I antibody (Fig 4C) .
RA induced the expression of ICAM-I in the parental and Ras-transfected HL-60 cells to a similar degree (Fig 5A) . The expression level of LFA-I did not change on RA stimulation and was similar in both cells (Fig 5A) . Furthermore, the LFA-IIICAM-1 -dependent adhesion of Ras-transfectants was not augmented compared with that of parental HL-60 cells (Figs 1B and 5B) . These data showed that activated Ras induced LFA-IIICAM-1 -dependent aggregation without any effect on the expression of LFA-IIICAM-I and the avidity of LFA-1. Inhibition o f aggregation o f Ras-traii.~fcctrriits by cytochalasin D and TGF0. Cytochalasin D TGFP. which had no effects on LFA-IIICAM-1 -dependent adhesion, prevented the formation of cellular aggregation (Fig 6) . Cytochalasin D and TGFD did not influence the expression of ICAM-1 (data not shown). Thus, in contrast to the adhesion. the aggregation was sensitive to treatment with cytochalasin D and TGF0. As expected, actinomycin D or cycloheximide, the agents that inhibited the activation of LFA-I as shown in Fig 3, prevented LFA-I/ICAM-I -dependent aggregation of Ras-transfectants by RA (Fig 6) . Wortmannin did not affect the aggregation (Fig 6) .
The efects o f Ras on po1ymeri:arion of actin and the expressions of contractile proteins. Filamentous actin (Factin) levels have been measured by phalloidin staining. The F-actin content was increased in Ras-transfectants in a Cd--dependent manner (Fig 7A) . RA stimulation had little effect on the F-actin content in parental and Ras-transfected HL-60 cells (data not shown). Paxillin was not expressed in unstimulated cells and was induced equally in parental and Ras-transfected HL-60 cells after RA stimulation (Fig 7B) . The representative cytoskeletal proteins, actin. actinin. talin. and vinculin, which were expressed constitutively at similar levels, were unchanged after RA stimulation in parental cells and Ras-transfectants.
and c~toskeletoii-dependelit hrosine phosphonlatiori
of paxillin in Ras-tmnsfectants by RA stimulation. To understand the molecular mechanisms of cellular aggregation induced in Ras-transfectants, we investigated the tyrosine phosphorylation of paxillin after RA stimulation because its phosphorylation causes 02 integrin-dependent cytoskeletal reorganization.'"'6 The lysates from nontreated or RAtreated parental or Ras-transfected HL-60 cells were immunoprecipitated with the monoclonal antipaxillin antibody, and the precipitates were analyzed by immunoblotting using the '"I-labeled antiphosphotyrosine antibody (PY-20). Paxillin was tyrosine-phosphorylated in Ras-transfectants. but not in parental cells, by RA stimulation (Fig 8A) . On the other hand, Fgr, the tyrosine phosphorylation of which was induced on RA stimulation (unpublished data). was tyrosinephosphorylated to a similar extent in both parental and Rastransfected HL-60 cells by RA stimulation (Fig 8A) .
The tyrosine phosphorylation of paxillin in Ras-transfectants was not induced when the cells were incubated with RA in the presence of the anti-02 antibody, cytochalasin D. or TFGP (Fig 8B) , all of which prevented the aggregation (Fig 6) . The anti-02 antibody is a blocking antibody and inhibited a ligation of 0 2 to its ligands, which led to preven- 
+TGF
DISCUSSION
In this study, we demonstrated that LFA-IDCAM-I -dependent adhesion and aggregation of HL-60 cells induced to differentiate into neutrophils required distinct regulatory processes, an increase in the avidity of LFA-I, and Rasdependent cytoskeletal reorganization, respectively.
RA induced the high avidity state of LFA-I. The fact that modulation of the avidity required de novo protein synthesis suggests that the existence of protein components keeps toxin, a specific inhibitor of Rho.49 This indicates that the integrity of the actin cytoskeleton is not essential for the activation of LFA-1 in RA-treated HL-60 cells. Therefore, the RA-induced molecule(s) that controls the high avidity state of LFA-1 might not be directly associated with the actin cytoskeleton. Interestingly, this molecule(s) seems to be different from the one necessary for the activation of /3l integrin because /3l integrin-dependent adhesion to fibronectin was induced by TPA in HL-60 cells without accompanying /32 integrin (LFA-I)-dependent adhesion. This result For personal use only. on October 27, 2017. by guest www.bloodjournal.org From suggests that molecular mechanisms that control P l -and PZdependent adhesion could be different.
The activation of LFA-1 was not sufficient for the induction of aggregation in RA-treated HL-60 cells. We showed that the activated Ras induced LFA-l/ICAM-1 -dependent aggregation of HL-60 cells. Ras was found to be involved in integrin-mediated signal transduction, suggesting its roles in postcell-adhesion events." Our previous report described that Ras was not activated in RA-treated HL-60
It seems that Ras activation is an important process for induction of aggregation. Recent studies showed that LFA-l/ICAM-1 -mediated aggregation was dependent on the actin cytoskeleton and tyrosine phosphorylation in cell-to-cell contact sites:' and that the cytoskeletal protein, paxillin, was tyrosine-phosphorylated on stimulation through P2 integrin and present in adhesion sites in neutrophil^?^.^^ Consistent with these studies, on the induction of aggregation, paxillin was tyrosine-phosphorylated, and the F-actin content increased in Ras-transfected HL-60 cells. Ras was demonstrated to sequentially activate Rac and Rh0.32-35 RaclRho induce tyrosine phosphorylation of paxillin and actin polymerization and stimulate the accumulation of tyrosine-phosphorylated paxillin and F-actin at adhesion site^.^*-'^ The C3 toxin, an inhibitor of Rho, was reported to inhibit LFA-l/ICAM-1 -dependent aggregati~n.~~ In the current study, the C3 toxin prevented the formation of the large aggregation in Ras-transfectants (data not shown). We hypothesize that activation of Ras by integrins or other stimuli causes sequential activation of Rac and Rho, which induces the assembly of specific cytoskeletal proteins at the plasma membrane to trigger the aggregation process.
Our results demonstrated that TGFP selectively inhibited LFA-l/ICAM-1 -dependent aggregation of RA-treated HL-60 cells without affecting the expression and the avidity of LFA-1. Recently, it was reported that TGFP caused a downregulation of some of the Src family kinases as the mechanism for its action on the suppression of cell growth, suggesting that tyrosine kinases are target molecules of TGFP for its suppressive effects?' TGFP prevented PZdependent tyrosine phosphorylation of paxillin. However, TGFP did not suppress the activities of Fgr and Lyn, which were predominantly expressed by RA-treated HL-60 cells (data not shown). ~1 2 5~~~ was not detected in RA-treated HL-60 cells (data not shown). Thus, tyrosine kinases responsible for tyrosine phosphorylation of paxillin remains to be elucidated. It is well known that when PMN aggregates, a LFA-1 -mediated signal can trigger generation of toxic products such as hydrogen peroxide."-54 Therefore, the function of TGFP observed here may be implicated in the physiological protection system against tissue injury in the inflammatory site. Identification of the tyrosine kinases involved in paxillin phosphorylation and clarification of the inhibitory mechanism by TGFP are important to understand the regulation of aggregation and immune responses.
In conclusion, our experimental system provides a new opportunity to dissect molecular mechanisms of cell adhesion and aggregation, as well as development of a new strategy to regulate immune responses. 
